| 产品详情 |
| Edit |   |
|---|
| Product Name | ERG Blocking Peptide |
|---|
| Description | Purity >50%, by HPLC. The ERG Blocking Peptide from Novus Biologicals is derived from Synthetic. The ERG Blocking Peptide has been validated for the following applications: Antibody Competition. |
|---|
| Size | 0.1 mg |
|---|
| Concentration | lyophilized |
|---|
| Applications | Antibody Competition |
|---|
| Other Names | transcriptional regulator ERG, 10ets-related, erg-3, p55, TMPRSS2-ERG prostate cancer specific, transcriptional regulator ERG, Transforming protein ERG, v-ets erythroblastosis virus E26 oncogene homolog (avian), v-ets erythroblastosis virus E26 oncogene like, v-ets erythroblastosis virus E26 oncogene like (avian) |
|---|
| Gene, Accession, CAS # | ERG, Gene ID: 2078, SwissProt: NP_891548.1 |
|---|
| Catalog # | NB100-2472PEP |
|---|
| Price | |
|---|
| Order / More Info | ERG Blocking Peptide from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|